4//SEC Filing
Rice Steven J. 4
Accession 0001209191-23-012994
CIK 0001706431other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 8:28 PM ET
Size
9.0 KB
Accession
0001209191-23-012994
Insider Transaction Report
Form 4
Rice Steven J.
Chief Administrative Officer
Transactions
- Award
Common Stock
2023-02-22+73,000→ 110,209 total - Award
Stock Option (Right to Buy)
2023-02-22+46,000→ 46,000 totalExercise: $27.01Exp: 2033-02-21→ Common Stock (46,000 underlying) - Sale
Common Stock
2023-02-23$25.97/sh−1,795$46,622→ 108,414 total
Footnotes (3)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F3]25% of the shares subject to the stock option vest and become exercisable on February 22, 2024, and the remainder vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001820108
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 8:28 PM ET
- Size
- 9.0 KB